Uterine Cancer Treatment in Israel takes place at state-of-the-art Assuta Medical Center in Tel Aviv. Please find the program below:
Our representative will pick you up from the airport and drive you to your hotel.
Manor’s coordinator/translator will drive you to your medical appointments, the first of which is laboratory tests (including specific tumour markers). Please note that if you have slides from a previous biopsy with you, we will have them reviewed by a local pathologist. The results of the revision will be completed on the evening of day 3.
A radiological study and PET/CT scan will also take place on day 2. This will help determine the size of the tumour and whether the disease has metastasized. The PET will be interpreted by the evening of the day 3. Finally, the patient will be examined by a senior oncological gynecologist, who will perform a biopsy (if needed). The results of the pathological study will be read on the evening of the day 4.
As mentioned above, the procedures will take place at Assuta Medical Center.
Cost of the program includes:
If no metastases are detected, but the patient is not of child-bearing age or is not interested in having children in the future, the work-up is considered complete, and a surgery is scheduled. However, if the patient does wish to have children in the future, in the absence of contraindications, a combined hormonal treatment protocol will be drawn up, which will allow her to fall pregnant in the future, whether naturally or by means of ART (IVF).
In cases of uterine carcinoma or sarcoma the main treatment option is radical hysterectomy. Provided the procedure is deemed necessary, the cost of the operation will include:
It is advised you remain in Israel for 8 days following your discharge from the hospital.
Hormonal treatment is indicated when the patient is interested in a pregnancy in the near future and no metastases or signs of pelvic lymphadenopathy have been detected. In such case, the patient will be prescribed Megace (160 mg/d) for 1 month. A follow-up PET/CT and pelvic MRI scans will take place once the treatment course has finished. In the event a good response is noted, the treating physicians will recommend either a Mirena IUD or continuing treatment with Megace. If further improvement is noted, the patient will be advised to fall pregnant as quickly as possible (IVF is advised).
In cases where the tumour has metastasized, the usual choice of uterine cancer treatment is chemotherapy with or without radiation therapy. In this case, the patient’s treating physician will be a medical oncologist.
Manor Medical Group also offers local and systemic hormonal therapy according to innovative protocols for young female patients, who are interested to give birth in the future
** Please note that the procedure can be performed utilizing the robotic da Vinci Surgical System. This will significantly decrease post-operative pain and shorten your recovery period.